Therapy with recombinant human insulin-like growth factor I in children with growth hormone receptor insufficiency (Larone’s syndrome)
https://doi.org/10.14341/probl11815
Abstract
Twenty-seven patients (14 - female, 13 - male; 3 - having achieved puberty) with growth hormone receptor deficiency (Laron syndrome) received treatment with recombinant insulin-like growth factor 1 (IGF-1) at a dose of 40-120 mcg per 1 kg body weight 2 times a day for 12 months. SDS for growth at the beginning of treatment ranged from -9.1 to -3.2 (age 3.7-22.9 years). Before treatment, most patients had an increased basal concentration in the serum of growth hormone (2.4–208 mU/L) and a low serum concentration of IGF-1 (<20–69 μg/L), IGF-2 (69–295 μg/L) and IRF-binding protein-3 (0.16-1.59 mg/l). In all but the two oldest patients, the growth rate increased by more than 2 cm / year compared with those before treatment. Asymptomatic hypoglycemia (blood glucose level <3.0 mmol / L) was recorded in 10 patients in 0.7% of measurements. In 4 patients symptomatic hypoglycemia was noted. Most patients after injections showed a transient decrease in serum potassium levels.
About the Authors
P WiltonKabi Pharmacia
Sweden
Kabi Pharmacia Research Group for therapy with insulin-like growth factor-I of patients with growth hormone insensitivity
Kabi Pharmacia
Sweden
References
1. Laron Z., Pertzelan A., Karp М. et al. // J. clin. Endocr.— 1971,—Vol. 64.— P. 1Q42—1046.
2. Golde D. U7., Bersch N., Kaplan S. A. et al. // New Engl. J. Med.— 1980,—Vol. 303.—P. 1156—1159.
3. Laron Z., Klinger B., Erster B., Silbergeld A. // Acta endocr. (Kbh.).— 1988,—Vol. 121,— P. 603—608.
4. Rosenbloom A. L., Aguirre J. G., Rosenfeld R. G., Fielder P. I. 11 New Engl. J. Med.— 1990,—Vol. 323.— P. 1367—1374.
5. Laron Z., Pertzelan A., Mannheimer S. // Isr. J. med. Sci.— 1966,— Vol. 2,— P. 152—155.
6. Eshet R., Laron Z., Pertzelan A. et al. // Ibid.— 1984.— Vol. 20,— P. 8—11.
7. Godowski P. J., Leung D. W'., Meacham L. R. et al. // Proc. nat. Acad. Sci. USA.— 1989,—Vol. 86.—P. 8083— 8087.
8. Amselem S., Duquesnoy P., Attree O. et al. // New Engl. J. Med.— 1989,—Vol. 321,—P. 989—995.
9. Meacham L. R., Murphy T. C., Klinger B. et al. // Proceedings of the 72-d Annual Meeting of the US Endocrine Society.— Atlanta, 1990.— Abstr. 1393.
10. Bang P., Eriksson U., Sara V. et al. // Acta endocr. (Kbh.).— 1991.-Vol. 124,—P. 620-629.
11. Blum W. F„ Ranke M. B„ Bierich J. R. 11 Ibid.— 1988.— Vol. 118.—P. 374-380.
12. Blum IF. F., Ranke M. B., Kietzmann K- et al. // J. clin. Endocr.— 1990,—Vol. 70,—P. 1292—1298.
13. Tar A., Hocquette J. F., Souberbielle J. C. et al. // Ibid.— Vol. 71.— P. 1202—1207.
14. Laron Z., Klinger B., Jensen L. T., Erster В. 11 Clin. Endocr.— 1991.—Vol. 35,—P. 145—150.
15. Walker J. L., Ginalsua-Malinowska M., Remer T. E. et al. // New Engl. J. Med.—1991.—Vol. 324,— P. 1483—1488.
16. Underwood L. E., Walker J. L., Pucilowska J. B. et al. // Acta paediat. scand.— 1992.— Suppl. 383.— P. 149.
17. Laron Z., Anin S., Klipper-Aurbach Y., Kliner B. // Lancet.— 1992,—Vol. 339,—P. 1258-1261.
18. Rosenfeld R. G., Wilson D. M.. Lee P. D. K., Hintz R. L. // J. Pediat.— 1986.— Vol. 109.- P. 428-433.
19. Merimee T. J., Russell B., Quinn S., Riley W. // J. clin. Endocr.— 1991,—Vol. 73.—P. 1031 — 1037.
20. Guler H. P., Zapf J., Froesch E. R. // New Engl. J. Med.—1987, —Vol. 317.—P. 137—140.
21. Laron Z., Klinger B., Erster B„ Anin S. // Lancet.—1988—Vol. 2.—P. 1170—1172.
22. Laron Z., Klinger B., Silbergeld A. et al. // Acta endocr. (Kbh.).— 1990,—Vol. 123,— P. 378—382.
Review
For citations:
Wilton P., therapy with insulin-like growth factor-I of patients with growth hormone insensitivity K. Therapy with recombinant human insulin-like growth factor I in children with growth hormone receptor insufficiency (Larone’s syndrome). Problems of Endocrinology. 1994;40(2):78-82. (In Russ.) https://doi.org/10.14341/probl11815
Views:
423
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
.jpg){kind=logo}
